Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
19:37:45 EDT Fri 26 Apr 2024
Enter Symbol
or Name
USA
CA



T:CRDL - CARDIOL THERAPEUTICS INC. CL 'A' - http://cardiolrx.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CRDL - T  1.02.45·2.503.42.45-0.05-2.058.71342142.50  2.50  2.412.94  0.7416:00:00Apr 1715 min RT 2¢
TSX - T1.02.45·2.503.42.45-0.05-2.029.768982.50  2.50  2.412.94  0.7416:00:0015 min
NEO ATS - U 2.44-0.06-2.41.0292.45  2.45  2.4315:45:2015 min
Alpha - A 2.46-0.04-1.65.41372.49  2.49  2.4515:59:4815 min
Omega - O 2.45-0.05-2.00.9242.41  2.45  2.4115:59:4815 min
Pure - P 2.43-0.07-2.80.2022.41  2.43  2.4115:45:2015 min
Chi-X - X 2.46-0.04-1.66.515262.45  2.47  2.4215:59:4815 min
CX2 - H 2.46-0.04-1.614.733522.49  2.49  2.4215:59:4815 min
CXD - D 2.500.105    Apr 2515 min
TriAct - M 2.500.2011    Sep 11-2015 min

Recent Trades - Last 10 of 214
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00T2.45-0.0560022 Fidelity1 AnonymousKQ
16:00:00T2.45-0.0550022 Fidelity1 AnonymousKQ
15:59:59M2.45-0.0571 Anonymous80 National BankE
15:59:56T2.43-0.0710079 CIBC79 CIBCK
15:59:56T2.43-0.0710019 Desjardins79 CIBCK
15:59:56T2.43-0.073001 Anonymous79 CIBCK
15:59:56T2.43-0.072005 Citadel79 CIBCK
15:59:48A2.46-0.041001 Anonymous79 CIBCK
15:59:48A2.46-0.041,9001 Anonymous79 CIBCK
15:59:48X2.46-0.041,5001 Anonymous79 CIBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-17 13:49C:CRDL2.415Warrants ExpireCardiol Therapeutics warrants to expire May 13
2024-04-02 09:26C:CRDL2.58News ReleaseCardiol Therapeutics recaps 2023 operations
2024-04-01 19:04C:CRDL2.58SEDAR Annual ReportSEDAR Annual Report
2024-04-01 18:57C:CRDL2.58SEDAR MD & ASEDAR MD & A
2024-04-01 18:45C:CRDL2.58SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-02-21 11:23C:CRDL2.25News ReleaseCardiol completes patient enrolment for CardiolRx study
2024-02-15 09:28C:CRDL1.42News ReleaseCardiol receives orphan drug designation for CardiolRx
2024-01-24 11:08C:CRDL1.52News ReleaseCardiol regains Nasdaq listing standard compliance
2024-01-09 11:35C:CRDL1.36News ReleaseCardiol enrolls over 50% of patients in Archer study
2023-12-05 11:11C:CRDL1.29News ReleaseCardiol adds Mass. General Hospital to CardiolRx study
2023-11-16 09:18C:CRDL1.14News ReleaseCardiol presents CardiolRx study results at MPD2023
2023-11-14 16:45C:CRDL1.19SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-14 16:41C:CRDL1.19SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-01 10:27C:CRDL1.17News ReleaseCardiol enrolls over 50% of patients in CardiolRx study
2023-10-20 17:16C:CRDL0.94News ReleaseCardiol's share price sinks below Nasdaq $1 (U.S.) min.
2023-10-10 10:00C:CRDL1.18News ReleaseCardiol's CRD-38 study shows cardioprotective effects
2023-09-19 10:39C:CRDL1.31News ReleaseCardiol expects full enrolment in Archer phase 2 trial
2023-08-10 17:07C:CRDL1.31SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-08 12:53C:CRDL1.60News ReleaseCardiol Therapeutics meets Nasdaq minimum bid price
2023-06-29 16:13C:CRDL1.06News ReleaseCardiol shareholders elect eight directors at AGM